Glycine Reuptake Inhibition as a New Therapeutic Approach in Schizophrenia: Focus on the Glycine Transporter 1 (GlyT1)

By  

Current Pharmaceutical Design, Vol. 19, Iss. 7, 2013-02 ,pp. : 1311-1320

Bentham Science Publishers

Access to resources Recommend Favorite

Glycine Transporter-1: A New Potential Therapeutic Target for Schizophrenia

By  

Current Pharmaceutical Design, Vol. 17, Iss. 2, 2011-01 ,pp. : 112-120

Bentham Science Publishers

Access to resources Recommend Favorite

Glycine Transporter-1 Inhibitors as Novel Therapeutic Drugs for Schizophrenia

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 7, Iss. 3, 2007-09 ,pp. : 177-182

Bentham Science Publishers

Access to resources Recommend Favorite

Glycine Site Modulators and Glycine Transporter-1 Inhibitors as Novel Therapeutic Targets for the Treatment of Schizophrenia

By  

Current Neuropharmacology, Vol. 3, Iss. 1, 2005-01 ,pp. : 35-43

Bentham Science Publishers

Access to resources Recommend Favorite

Glycine Transporter Type-1 and its Inhibitors

By  

Current Medicinal Chemistry, Vol. 13, Iss. 9, 2006-04 ,pp. : 1017-1044

Bentham Science Publishers

Access to resources Recommend Favorite